Physical stress as a model to study variations in ADAMTS-13 activity, von Willebrand factor level and platelet activation [7]

Journal of Thrombosis and Haemostasis

Volumn 4, Issue 4, 2006, Pages 902-905

  Claus, Ralf A ^a   Bockmeyer, C L ^a   Sossdorf, M ^a   Losche W ^a   Hilberg, T ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; ADRENALIN; FIBRINOGEN RECEPTOR; INTERLEUKIN 6; PADGEM PROTEIN; VASOPRESSIN; VON WILLEBRAND FACTOR; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ANAEROBIC THRESHOLD; ANALYSIS OF VARIANCE; BINDING AFFINITY; CELL ACTIVATION; DISEASE ASSOCIATION; ENDOTHELIUM CELL; ENDOTOXEMIA; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; HEART ARREST; HIGH RISK PATIENT; HUMAN; LETTER; PATHOPHYSIOLOGY; PHYSICAL STRESS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; RISK ASSESSMENT; SHEAR STRESS; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOGENESIS; TRANSCRIPTION REGULATION; TREADMILL EXERCISE; VEIN THROMBOSIS;

ADAM PROTEINS; ENDOTHELIAL CELLS; EXERCISE; HEMOSTASIS; HUMANS; INFLAMMATION; P-SELECTIN; PLATELET ACTIVATION; TIME FACTORS; VON WILLEBRAND FACTOR;

EID: 33644978281     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2006.01837.x     Document Type: Letter

References (28)

1. Wang JS, Chow SE, Chen JK. Strenuous, acute exercise affects reciprocal modulation of platelet and polymorphonuclear leukocyte activities under shear flow in men. J Thromb Haemost 2003; 1: 2031-7.
2. El-Sayed MS, Sale C, Jones PG, Chester M. Blood hemostasis in exercise and training. Med Sci Sports Exerc 2000; 32: 918-25.
3. Hilberg T, Schmidt V, Glaser D, Schammne D, Losche W, Gabriel HH. Platelet activity, sensitivity to agonist, and platelet-leukocyte conjugate formation after long-term exercise. Platelets 2002; 13: 273-7.
4. Kestin AS, Ellis PA, Barnard MR, Errichetti A, Rosner BA, Michelson AD. Effect of strenuous exercise on platelet activation state and reactivity. Circulation 1993; 88: 1502-11.
5. Romani Wit de T, Rondaij MG, Hordijk PL, Voorberg J, van Mourik JA. Real-time imaging of the dynamics and secretory behaviour of Weibel-Palade bodies. Arterioscler Thromb Vasc Biol 2003; 23: 755-61.
6. Arya M, Anvari B, Romo GM, Cruz MA, Dong JF, McIntire LV, Moake JL, Lopez JA. Ultralarge multimers of von Willebrand factor form spontaneous high-strength bonds with the platelet glycoprotein Ib-IX complex: studies using optical tweezers. Blood 2002; 99: 3971-7.
7. Levy GG, Motto DG, Ginsburg D. ADAMTS13 turns 3. Blood 2005; 106: 11-7.
8. Mannucci PM, Canciani MT, Forza I, Lussana F, Lattuada A, Rossi E. Changes in health and disease of the metalloprotease that cleaves von Willebrand factor. Blood 2001; 98: 2730-5.
9. Mannucci PM, Capoferri C, Canciani MT. Plasma levels of von Willebrand factor regulate ADAMTS-13, its major cleaving protease. Br J Haematol 2004; 126: 213-8.
10. Reiter RA, Knobl P, Varadi K, Turecek PL. Changes in von Willebrand factor-cleaving protease (ADAMTS13) activity after infusion of desmopressin. Blood 2003; 101: 946-8.
11. Reiter RA, Varadi K, Turecek PL, Jilma B, Knobl P. Changes in ADAMTS13 (von-Willebrand-factor-cleaving protease) activity after induced release of von Willebrand factor during acute systemic inflammation. Thromb Haemost 2005; 93: 554-8.
12. Bernardo A, Ball C, Nolasco L, Moake JF, Dong JF. Effects of inflammatory cytokines on the release and cleavage of the endothelial cell-derived ultralarge von Willebrand factor multimers under flow. Blood 2004; 104: 100-6.
13. Hilberg T, Deigner HP, Moller E, Claus RA, Ruryk A, Glaser D, Landre J, Brunkhorst FM, Reinhart K, Gabriel HH, Russwurm S. Transcription in response to physical stress - clues to the molecular mechanisms of exercise-induced asthma. FASEB J 2005; 19: 1492-4.
14. Kokame K, Nobe Y, Kokubo Y, Okayama A, Miyata T. FRETS-VWF73, a first fluorogenic substrate for ADAMTS13 assay. Br J Haematol 2005; 129: 93-100.
15. Gabriel H, Schwarz L, Steffens G, Kindermann W. Immunoregulatory hormones, circulating leucocyte and lymphocyte subpopulations before and after endurance exercise of different intensities. Int J Sports Med 1992; 13: 359-66.
16. Rondaij MG, Sellink E, Gijzen KA, ten Klooster JP, Hordijk PL, van Mourik JA, Voorberg J. Small GTP-binding protein Ral is involved in cAMP-mediated release of von Willebrand factor from endothelial cells. Arterioscler Thromb Vasc Biol 2004; 24: 1315-20.
17. Andre P. P-selectin in haemostasis. Br J Haematol 2004; 126: 298-306.
18. Claus RA, Bockmeyer CL, Kentouche K, Sieber MW, Oberle V, Kaufmann R, Deigner HP, Losche W. Transcriptional regulation of ADAMTS13. Thromb Haemost 2005; 94: 41-5.
19. Lopez JA, Dong JF. Cleavage of von Willebrand factor by ADAMTS-13 on endothelial cells. Semin Hematol 2004; 41: 15-23.
20. Padilla A, Moake JL, Bernardo A, Ball C, Wang Y, Arya M, Nolasco L, Turner N, Berndt MC, Anvari B, Lopez JA, Dong JF. P-selectin anchors newly released ultralarge von Willebrand factor multimers to the endothelial cell surface. Blood 2004; 103: 2150-6.
21. Ferroni P, Pulcinelli FM, Lenti L, Gazzaniga PP. Is soluble P-selectin determination a more reliable marker of in vivo platelet activation than CD62P flow cytometric analysis. Thromb Haemost 1999; 81: 472-3.
22. El-Sayed MS. Exercise and training effects on platelets in health and disease. Platelets 2002; 13: 261-6.
23. Hilberg T, Glaser D, Schmidt V, Losche W, Franke G, Schneider K, Gabriel HH. Short-term exercise and platelet activity, sensitivity to agonist, and platelet-leukocyte conjugate formation. Platelets 2003; 14: 67-74.
24. Hilberg T, Eichler E, Glaser D, Schmidt V, Gabriel HH. Platelet activity, reactivity and platelet-leukocyte conjugate formation before and after exhaustive or moderate exercise in patients with IDDM. Platelets 2004; 15: 101-8.
25. Wun T, Paglieroni T, Lachant NA. Physiologic concentrations of arginine vasopressin activate human platelets in vitro. Br J Haematol 1996; 92: 968-72.
26. Tahara A, Tsukada J, Ishii N, Tomura Y, Wada K, Kusayama T, Yatsu T, Uchida W, Tanaka A. Comparison of vasopressin binding sites in human uterine and vascular smooth muscle cells. Eur J Pharmacol 1999; 378: 137-42.
27. Mannucci PM. Desmopressin (DDAVP) in the treatment of bleeding disorders: The first 20 years. Blood 1997; 90: 2515-21.
28. Thibonnier M. Vasopressin agonists and antagonists. Horm Res 1990; 34: 124-8.